• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哌甲酯依从性的决定因素以及依从性差对母亲和家庭指标的影响。

Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures.

作者信息

Gau Susan S F, Shen Hsin-Yi, Chou Miao-Churn, Tang Ching-Shu, Chiu Yen-Nan, Gau Churn-Shiouh

机构信息

Department of Psychiatry, National Taiwan University, No. 1 Jen-Ai Road Section 1, Taipei, Taiwan 10051.

出版信息

J Child Adolesc Psychopharmacol. 2006 Jun;16(3):286-97. doi: 10.1089/cap.2006.16.286.

DOI:10.1089/cap.2006.16.286
PMID:16768636
Abstract

OBJECTIVE

The aim of this study was to examine the association between adherence to immediate-release methylphenidate (IR MPH) and maternal psychological distress, parenting style, parent- child relationship, and perceived family support.

METHODS

The sample consisted of 307 children with attention-deficit hyperactivity disorder (ADHD) (271 boys and 36 girls), 6-17 years of age, who had been treated with IR MPH for the past 6 months. The measures included the Chinese Health Questionnaire, Parental Bonding Instrument, Family APGAR, and Home Behaviors of the Social Adjustment Inventory for Children and Adolescents.

RESULTS

Reasons for poor adherence (n = 79; 25.7%) included forgetting medication (72.7%), the medication having no effect (20.0%), and refusing medication (12.7%). Increased age and three-times-daily administration were the major predictors for poor adherence to IR MPH. Poor adherence was associated with increased degree of maternal psychological distress, indifferent parenting, maternal overprotection/control, poor family support, decreased interaction with parents, and increased problems at home.

CONCLUSIONS

Findings indicate that multiple daily dosing of MPH increases the likelihood of poor adherence, particularly in adolescents, and that poor adherence is associated with impaired maternal/family process. Once-daily administration of MPH is necessary to improve adherence and to decrease the possible exacerbation of tense parent-child relationships caused by poor drug adherence.

摘要

目的

本研究旨在探讨速释型哌甲酯(IR MPH)的服药依从性与母亲心理困扰、育儿方式、亲子关系及感知到的家庭支持之间的关联。

方法

样本包括307名6至17岁患有注意力缺陷多动障碍(ADHD)的儿童(271名男孩和36名女孩),他们在过去6个月接受了IR MPH治疗。测量工具包括中国健康问卷、父母教养方式问卷、家庭APGAR问卷以及儿童青少年社会适应量表中的家庭行为部分。

结果

依从性差的原因(n = 79;25.7%)包括忘记服药(72.7%)、药物无效(20.0%)和拒绝服药(12.7%)。年龄增长和每日三次服药是IR MPH服药依从性差的主要预测因素。依从性差与母亲心理困扰程度增加、冷漠的育儿方式、母亲过度保护/控制、家庭支持不足、与父母互动减少以及家庭问题增多有关。

结论

研究结果表明,MPH每日多次给药会增加依从性差的可能性,尤其是在青少年中,且依从性差与母亲/家庭过程受损有关。MPH每日一次给药对于提高依从性以及减少因药物依从性差导致的紧张亲子关系可能加剧的情况是必要的。

相似文献

1
Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures.哌甲酯依从性的决定因素以及依从性差对母亲和家庭指标的影响。
J Child Adolesc Psychopharmacol. 2006 Jun;16(3):286-97. doi: 10.1089/cap.2006.16.286.
2
Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.在三种注意缺陷多动障碍(ADHD)亚型中,对于速释型哌甲酯依从性差的患者,渗透型口服系统哌甲酯疗效更佳。
Psychiatry Clin Neurosci. 2009 Apr;63(2):167-75. doi: 10.1111/j.1440-1819.2009.01937.x.
3
National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.台湾地区注意力缺陷多动障碍儿童使用哌甲酯的依从性、疗效及副作用的全国性调查。
J Clin Psychiatry. 2008 Jan;69(1):131-40. doi: 10.4088/jcp.v69n0118.
4
Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH.探索每日一次 OROS®哌甲酯(MPH)对从速释 MPH 转换的 ADHD 儿童和青少年的症状和生活质量的影响。
Postgrad Med. 2011 Sep;123(5):27-38. doi: 10.3810/pgm.2011.09.2457.
5
Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder.哌甲酯渗透控释口服给药系统治疗可减轻患有注意力缺陷多动障碍的儿童和青少年的父母的育儿压力。
Hum Psychopharmacol. 2013 Nov;28(6):600-7. doi: 10.1002/hup.2363.
6
Effect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatment.用于治疗注意力缺陷多动障碍的哌甲酯制剂对治疗模式和结果的影响。
J Child Adolesc Psychopharmacol. 2004 Winter;14(4):575-81. doi: 10.1089/cap.2004.14.575.
7
Naturalistic exploration of the effect of osmotic release oral system-methylphenidate on remission rate and functional improvement in Taiwanese children with attention-deficit-hyperactivity disorder.自然探索渗透型释放口崩型哌甲酯对台湾地区注意缺陷多动障碍儿童缓解率和功能改善的效果。
Psychiatry Clin Neurosci. 2012 Feb;66(1):53-63. doi: 10.1111/j.1440-1819.2011.02289.x.
8
Switching from immediate release to sustained release methylphenidate in the treatment of children and adolescents with attention deficit/hyperactivity disorder.将速释型哌甲酯转换为控释型哌甲酯治疗注意缺陷多动障碍儿童和青少年。
Eur Rev Med Pharmacol Sci. 2013 Sep;17(17):2345-9.
9
Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study.在 ADHD 儿童/青少年中,从缓释哌甲酯转换为渗透控释哌甲酯的效果:一项 3 个月非干预性研究的结果。
Curr Med Res Opin. 2011;27 Suppl 2:35-44. doi: 10.1185/03007995.2011.601733. Epub 2011 Jul 25.
10
Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.从阿托莫西汀转换为奥洛他定(®)哌甲酯对 ADHD 儿童和青少年有效。
Expert Rev Neurother. 2011 Apr;11(4):499-508. doi: 10.1586/ern.11.18.

引用本文的文献

1
Problematic Smartphone Use in Adolescents with Attention-Deficit/Hyperactivity Disorder: The Roles of Domestic Violence, Parenting Styles, and Peer Bullying Victimization.注意力缺陷多动障碍青少年的问题智能手机使用:家庭暴力、养育方式和同伴欺凌受害经历的作用
Int J Med Sci. 2025 Jun 23;22(12):3112-3119. doi: 10.7150/ijms.112302. eCollection 2025.
2
Medication adherence and persistence in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and qualitative update.注意缺陷多动障碍(ADHD)儿童及青少年的药物依从性和持续性:一项系统综述及定性更新
Eur Child Adolesc Psychiatry. 2025 Mar;34(3):867-882. doi: 10.1007/s00787-024-02538-z. Epub 2024 Aug 6.
3
Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review.
青少年注意缺陷多动障碍患者药物治疗依从性不佳的短期和长期结局:系统文献综述。
J Child Adolesc Psychopharmacol. 2024 May;34(4):183-193. doi: 10.1089/cap.2024.0018. Epub 2024 May 3.
4
Caregiving burden and special needs of parents in the care of their short-statured children - a qualitative approach.照顾矮小儿童的父母的照顾负担和特殊需求——一种定性方法。
Front Endocrinol (Lausanne). 2023 Mar 17;14:1093983. doi: 10.3389/fendo.2023.1093983. eCollection 2023.
5
Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study.注意缺陷多动障碍儿童和青少年治疗方案改变的原因:一项图表回顾性研究。
Adv Ther. 2022 Dec;39(12):5487-5503. doi: 10.1007/s12325-022-02329-5. Epub 2022 Oct 11.
6
Change in Adolescents' Perceived ADHD Symptoms Across 17 Days of Ecological Momentary Assessment.青少年在 17 天的生态瞬间评估中感知 ADHD 症状的变化。
J Clin Child Adolesc Psychol. 2024 May-Jun;53(3):397-412. doi: 10.1080/15374416.2022.2096043. Epub 2022 Jul 26.
7
Toward Precision Medicine in ADHD.迈向注意缺陷多动障碍的精准医学
Front Behav Neurosci. 2022 Jul 6;16:900981. doi: 10.3389/fnbeh.2022.900981. eCollection 2022.
8
Affiliate Stigma in Caregivers of Children with Attention-Deficit/Hyperactivity Disorder: The Roles of Stress-Coping Orientations and Parental Child-Rearing Styles.注意缺陷多动障碍患儿照料者的附属耻辱感:压力应对取向和父母养育方式的作用。
Int J Environ Res Public Health. 2021 Aug 26;18(17):9004. doi: 10.3390/ijerph18179004.
9
Prescription patterns and medication adherence in preadolescent children with attention deficit hyperactivity disorder.患有注意力缺陷多动障碍的青春期前儿童的处方模式与药物依从性
Indian J Psychiatry. 2021 May-Jun;63(3):274-278. doi: 10.4103/psychiatry.IndianJPsychiatry_782_20. Epub 2021 Jun 17.
10
Strategies for improving ADHD medication adherence.提高注意力缺陷多动障碍药物依从性的策略。
Curr Psychiatr. 2019 Aug;18(8):25-38.